Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Net Margin (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Net Margin data on record, last reported at 233.41% in Q4 2025.

  • For Q4 2025, Net Margin fell 24030.0% year-over-year to 233.41%; the TTM value through Dec 2025 reached 29.78%, up 1741.0%, while the annual FY2025 figure was 131.95%, 14681.0% down from the prior year.
  • Net Margin reached 233.41% in Q4 2025 per COLL's latest filing, down from 144.75% in the prior quarter.
  • Across five years, Net Margin topped out at 89.23% in Q2 2021 and bottomed at 233.41% in Q4 2025.
  • Average Net Margin over 5 years is 13.42%, with a median of 6.37% recorded in 2024.
  • Peak YoY movement for Net Margin: soared 8594bps in 2022, then tumbled -24030bps in 2025.
  • A 5-year view of Net Margin shows it stood at 91.49% in 2021, then soared by 94bps to 5.55% in 2022, then surged by 662bps to 31.19% in 2023, then crashed by -78bps to 6.89% in 2024, then crashed by -3488bps to 233.41% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 233.41% in Q4 2025, 144.75% in Q3 2025, and 9.06% in Q2 2025.